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Introduction
Disinfection of water reduces pathogenic 
infection; however, water disinfectants also 
react with organic materials to generate disin-
fection by-products (DBP). Several hundred 
DBPs have been identified. Trihalomethanes 
(THM) are one of the most frequent classes of 
DBP detected in residential water (Richardson 
et al. 2007).
Several DBP compounds, such as bro-
minated THM (BTHM), are carcinogenic 
in rodents and are mutagenic in several tests 
[International Agency for Research on Cancer 
(IARC) 2004; Richardson et al. 2007]. There 
is epidemiologic evidence of an association 
between bladder cancer and exposure to DBP 
from residential water (Villanueva et al. 2004) 
and from bathing, showering, or swimming 
(Villanueva et al. 2006).
Micronuclei (MN) frequency is a well-
established biomarker of DNA damage 
(Fenech 2007). MN frequency in peripheral 
blood lymphocytes has been associated in a 
large prospective study with an increased risk 
of cancer among adults (Bonassi et al. 2011).
The frequency of MN has been reported 
to increase in exfoliated urine cells with 
THM exposures (Villaneuva et al. 2006). 
BTHM concentrations in exhaled breath 
have been associated with an increased fre-
quency of MN in lymphocytes and increased 
urinary mutagenicity in adults swimming in 
indoor pools (Kogevinas et al. 2010).
Little is known about potential mutagenic 
or carcinogenic effects of in utero exposures 
to DBP. The fetus may be more susceptible 
to environmental mutagens and carcinogens 
(Wild and Kleinjans 2003), and certain can-
cers may have a fetal origin (Gluckman et al. 
2008). With this in mind, we assessed the 
potential associations between exposure to 
BTHM during pregnancy and MN frequency 
in maternal and cord blood lymphocytes.
Methods
Study population. This study includes moth-
ers and newborns from the island of Crete, 
Greece, who were part of the Rhea cohort 
(Chatzi et al. 2009; Patelarou et al. 2011). 
Women who became pregnant during 
February 2007–February 2008 were asked to 
participate in the study. The first contact with 
potential participants was made at around 
10–13 weeks of pregnancy, at the time of the 
first ultrasound examination. Women were 
invited to provide blood and urine samples 
and complete face-to-face interviews if they 
were residents of the study area, > 16 years 
of age, visiting a participating hospital or 
private clinic during the 10th–13th week 
of gestation, and did not have communica-
tion limitations. Participating women were 
contacted again during the 14th–18th and 
28th–32nd weeks of pregnancy and at birth. 
During recruitment, 1,610 eligible women 
agreed to participate, and 1,459 (91%) were 
followed through delivery. A subset of 408 
participants donated maternal and/or cord 
blood for biomarker measurements as part of 
the NewGeneris study (Merlo et al. 2009). 
A total of 214 mothers and 223 newborns 
with MN analysis of maternal and cord blood 
lymphocytes from singleton pregnancies were 
included in this study. Of these, 162 were 
mother–child pairs.
A comparison of those who did and did 
not participate in the current study revealed 
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Background: Water disinfection by-products have been associated with an increased cancer risk. 
Micronuclei (MN) frequency in lymphocytes is a marker of genomic damage and can predict adult 
cancer risk.
oBjective: We evaluated maternal exposure to drinking water brominated trihalomethanes 
(BTHM) in relation to MN frequency in maternal and cord blood lymphocytes.
Methods: MN frequency was examined in 214 mothers and 223 newborns from the Rhea 
mother–child cohort in Crete, Greece, in 2007–2008. Residential BTHM water concentrations 
were estimated during pregnancy using tap water analyses and modeling. Questionnaires on water 
related habits were used to estimate BTHM exposure from all routes. Associations between BTHM 
and MN frequency were estimated using negative binomial regression.
results: BTHM concentrations in residential tap water during pregnancy ranged from 0.06 to 
7.1 μg/L. MN frequency in maternal binucleated lymphocytes was found to increase with BTHM con-
centrations in residential water for exposure during the first [rate ratio (RR) for 1 μg/L = 1.05; 95% CI: 
1.00, 1.11] and second trimesters (RR for 1 μg/L = 1.03; 95% CI: 1.00, 1.06), and through all routes of 
BTHM exposure during the first trimester (RR for 1 μg/week = 3.14; 95% CI: 1.16, 8.50).
conclusions: These findings suggest that exposure to BTHM may increase the frequency of MN 
in maternal binucleated lymphocytes.
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a small but significantly lower percentage 
of Greek women among those who partici-
pated in the study (87%) than among those 
who did not (92%). Otherwise the groups 
were very similar with regard to the study 
covariates (data not shown). Questionnaires 
elicited information on maternal character-
istics including ethnicity, age, prepregnancy 
body mass index (BMI), parity (none or 
≥ 1), smoking, secondhand tobacco smoke 
(SHS), supplement use, education, and water-
related habits during pregnancy (Patelarou 
et al. 2011). A food frequency questionnaire 
was used to assess dietary habits and adher-
ence to a Mediterranean diet (Chatzi et al. 
2012). Information on diabetes, gestational 
hypertension, and anthropometric measure-
ments at birth was obtained from medical 
records. Gestational age was based on the 
interval between the last menstrual period and 
the date of delivery for 84% of the women. 
When the last menstrual estimate was incon-
sistent by ≥ 7 days with the ultrasound 
measurement taken in the first trimester of 
pregnancy (16%), a quadratic regression for-
mula describing the relation between crown–
rump length and gestational age was used 
(Westerway et al. 2000).
The Ethics Committee of the University 
Hospital in Heraklion, Crete, Greece, 
approved the study. All participants provided 
written, informed consent for themselves and 
their child after having received a complete 
 description of the study.
DBP exposure assessment. As part of the 
European project HIWATE (Health Impacts 
of long-term exposure to disinfection byprod-
ucts in drinking Water), residential and 
maternal exposure to DBP during pregnancy 
was estimated using standardized methods 
(Nieuwenhuijsen et al. 2009; Patelarou et al. 
2011). Briefly, on the basis of information 
provided by the water company that supplies 
Heraklion, the city was divided into six zones 
according to the source of underground water 
used in each area that corresponded to the 
six water treatment plants supplying water. 
In total, 18 sampling points were selected 
(12 areas in Heraklion and 6 in rural areas), 
which covered geographically the residences 
of participating women. One household in 
each of the 18 areas, which was randomly 
selected, was visited four times at home to 
collect tap water samples between the months 
of September 2007 and January 2009 (72 
tap water samples in total). Samples were 
analyzed by gas chromatography/mass spec-
trometry for the four specific THMs: chloro-
form, bromoform, bromodichloromethane, 
and dibromochloromethane. BTHM con-
stituted > 80% of the total THM (Patelarou 
et al. 2011), so we decided to concentrate this 
analysis on exposures to BTHM. Residential 
addresses were assigned to a water supply 
zone based on the maternal address early in 
pregnancy. BTHM concentrations in resi-
dential water were estimated based on the 
residential water supply zone, and individual 
residential concentrations of BTHM (micro-
grams per liter of residential water) were pre-
dicted using generalized additive models for 
each month of pregnancy.
Average residential water BTHM concen-
trations were calculated for the entire preg-
nancy and for each trimester for both mothers 
and newborns. BTHM concentrations were 
assumed to be uniform within the water sup-
ply zones, so the potential spatial variation 
of BTHM concentrations within the water 
systems was not considered in the analysis. 
However, the areas covered by these systems 
were small, and little variation within the sys-
tems was expected (Symanski et al. 2004).
Information on maternal water usage 
habits during pregnancy was combined with 
estimated residential water concentrations 
to estimate maternal and prenatal BTHM 
exposures through all routes, including inges-
tion, dermal absorption, and inhalation 
( micrograms per week) (Patelarou et al. 2011).
MN frequency in maternal and cord 
blood lymphocytes. Maternal peripheral 
blood was collected by venipuncture 1 day 
after delivery, and cord blood was col-
lected by umbilical puncture from the pla-
centa immediately after delivery (Merlo 
et al. 2009). The blood for the cytokinesis-
block micro nuclei assay was kept in hepa-
rin tubes at 4°C. Whole-blood cultures with 
 phytohemagglutinin (PHA) stimulation 
were initiated within 24 hr after collection 
(Vande Loock et al. 2011). After 44 hr of 
incubation, cytochalasin B was added to the 
cultures to block the cell division and enable 
scoring of binucleated (BN; i.e., cells that 
have divided once, having two nuclei) lym-
phocytes. At 72 hr following PHA stimula-
tion, the cultures were harvested. A hypotonic 
treatment was used to remove the red blood 
cells; cells were fixed in freshly prepared 
methanol-acetic acid, and cell suspensions 
were dropped onto clean slides. Slides were 
stained and were examined in the Laboratory 
of Cell Genetics, Vrije Universiteit Brussel.
A semi-automated scoring procedure of 
the lymphocytes was carried out, using the 
PathFinder platform installed by Imstar 
(version 6; Paris, France). At the end of the 
automatic screening, lymphocytes contain-
ing detected MN were visually evaluated. 
After validation, the total numbers of BN 
and mononucleated (MONO) lympho-
cytes with MN, and the total number of 
lymphocytes counted for each participant, 
were recorded. The cytokinesis-block pro-
liferation index (CBPI) for each participant 
was calculated as follows: CBPI = (number of 
MONO + 2 × number of BN + 3 × number 
of polynucleated lymphocytes)/total num-
ber of lymphocytes counted (Decordier et al. 
2009). The design of the MN protocol aims 
at maximizing the number of BN lympho-
cytes, which results on average in a CBPI of 
2. Lower CBPI frequencies reflect cell cycle 
delay due to toxicity or cell immaturity, and 
higher CBPI frequencies result from excessive 
 mitogenic activation.
Statistical analyses. Descriptive analy-
ses of the study population characteristics, 
exposures, and outcomes were conducted. 
Negative binomial regression was used to 
model the MN counts using the GLM (gen-
eralized linear models) procedure in STATA 
11.0 and 13.0 (StataCorp, College Station, 
TX, USA). A natural log link was used, and 
the model included the number of either BN 
or MONO cells as an offset to control for the 
number of lymphocytes counted. We also 
evaluated Poisson regression as an alterna-
tive to negative binomial regression, but the 
latter provided a better fit to the data (data 
not shown). MN frequencies in maternal 
BN and MONO, and cord blood BN and 
MONO, were evaluated as outcomes using 
separate models to estimate associations of 
each outcome with BTHM concentrations in 
residential water (micrograms per liter; cate-
gorized into quartiles), and BTHM exposures 
through all routes (micrograms per week and 
as quartiles), for each trimester and for the 
entire pregnancy. In addition, we used sepa-
rate models to estimate associations of the 
outcomes with maternal water habits during 
early pregnancy, including bathing and show-
ering [evaluated separately according to fre-
quency (times per week), duration (minutes), 
or frequency × duration (minutes/week); and 
as shower only, bath only, or both], use of 
a swimming pool during pregnancy (any or 
none), hand dishwashing only (vs. any use 
of a dishwashing machine), and type of 
drinking water consumed (public, bottled, 
or spring water). Models were also fitted to 
evaluate the possible effect of clustering by the 
water systems by including a random effect 
for water systems using the VCE (variance 
covariance estimation) option in the STATA 
GLM procedure.
Covariates for control of potential con-
founding included a set of variables that 
were believed a priori to be determinants 
of MN. For mothers, the models included 
maternal age at birth (years), smoking dur-
ing pregnancy (nonsmoker/ex-smoker/active 
smoker), workplace and home exposure to 
SHS (no/yes), residence in an urban area 
(no/yes), education (low: ≤ 9 years educa-
tion; medium: 10–14 years education; high: 
university degree or higher), and ethnic-
ity (Greek/non-Greek). For newborns, the 
same covariates were included, except that 
gestational age (weeks) was substituted for 
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maternal age. Nonsmokers reported not 
smoking at any time for at least 3 months 
before pregnancy or during pregnancy; ex-
smokers reported smoking sometime within 
the 3 months before pregnancy and/or 
during the first 12 weeks of gestation, but 
not after then; and active smokers reported 
smoking 3 months before pregnancy and 
at approximately 12 weeks of gestation (the 
time of interview). In addition, potential 
confounding by prepregnancy maternal BMI 
(kilograms per meter squared), prior births 
(yes/no), Mediterranean diet (low, moderate, 
high), use of dietary supplements (yes/no), 
diabetes (yes/no), gestational hypertension 
(yes/no), and small for gestational age (yes/
no) was evaluated by fitting models with 
and without these covariates and monitoring 
changes in the regression coefficient of the 
exposure variables. Statistical testing and 95% 
CIs were estimated using robust standard 
errors. Restricted cubic spline models with 
3 knots were fitted based on Harrell’s recom-
mended percentiles to evaluate the linearity of 
associations. Statistical interactions between 
the exposure variables and all of the covariates 
were assessed by fitting models with cross-
product terms and testing their significance 
using a Wald test. The cross-product terms 
corresponding to categorical covariates with 
> 2 levels were tested as a group. Any interac-
tions that were found to be statistically sig-
nificant at the p < 0.05 level were included in 
the models.
The inclusion of numerous potential con-
founders in the analysis resulted in a large 
amount of missing data. To increase effi-
ciency and reduce selection bias, we applied 
multiple imputation methods. The imputa-
tion used all the available information on the 
individual characteristics of the entire study 
population and included all individuals who 
had MN data for either the mother or the 
child. To make the missing-at-random (MAR) 
assumption more plausible, we included many 
variables in the imputation model and used 
the chained equations procedure (White 
et al. 2011) under the MAR assumption. 
Categorical variables were modeled using 
logistic or ordinal models; non-normally dis-
tributed variables were log-transformed or 
imputed using predictive mean matching. All 
of the covariates were included in the model. 
We generated 30 complete data sets that were 
analyzed individually to obtain a set of param-
eters and then combined into overall estimates 
using Rubin’s rule (Rubin 1987).
Results
Study population characteristics. A sum-
mary of the variables used in the analysis 
for the combined population (n = 240) of 
mothers and newborns with complete MN 
and BTHM information for all and strati-
fied by quartiles of BTHM exposure averaged 
over the pregnancy is presented in Table 1. 
Most of the mothers were Greek (86%) 
and ≤ 35 years of age (88%). Most moth-
ers did not smoke during pregnancy (61%), 
but were exposed to SHS either at home or 
work (89%), had moderate education (53%), 
and lived in urban areas (72%). Most women 
drank bottled water (73%) and only used 
showers (vs. baths) (95%) during pregnancy. 
Six percent of the children were born before 
37 weeks of gestation. The mean (± SD) ges-
tational age was 38.4 ± 1.3 weeks, and mean 
birth weight was 3,225 ± 412 g.
All of the study covariates had missing 
data for some participants except sex and ges-
tational age. The percentage of missing values 
ranged from 0.4% (delivery mode) to 31% 
(Mediterranean diet). The percentage of par-
ticipants missing data for at least one of the 
final model covariates was 3%.
Maternal residence in an urban area 
(p < 0.001), and drinking-water source 
(p < 0.001) were the only covariates that were 
significantly associated with BHTM (Table 1). 
The percentage of women who were in the 
highest quartile of BTHM was higher for 
those living in an urban area (27%) than those 
Table 1. Study population characteristics [n (%)]a for all and by quartiles of the residential exposure to 
brominated trihalomethanes during the full pregnancy.b
Characteristic All (n = 240) Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-Valuec
Ethnicity 0.82
Greek 205 (86.3) 60 (88.2) 43 (84.3) 50 (83.3) 30 (88.1)
Other 33(13.9) 8 (11.8) 8 (15.7) 10 (16.7) 7 (11.9)
Missing 2 1 0 0 1
Maternal age (years) 0.24
≤ 35 210 (87.8) 65 (94.2) 44 (88.0) 50 (83.3) 51 (85.0)
> 35 29 (12.1) 4 (5.8) 6 (12.0) 10 (16.7) 9 (15.0)
Missing 1 0 1 0 0
Maternal smoking 0.06
Nonsmokers 145 (61.2) 45 (65.2) 33 (68.9) 28 (46.7) 39 (65.0)
Ex-smokers 44 (18.6) 16 (23.2) 5 (10.4) 14 (23.3) 9 (15.0)
Active smokers 48 (20.2) 8 (11.6) 10 (20.8) 18 (30.0) 12 (20.0)
Missing 3 0 3 0 3
SHSd 0.42
Not exposed 26 (10.9) 5 (7.3) 5 (10.0) 6 (10.0) 10 (16.7)
Exposed 213 (89.1) 64 (92.8) 45 (90.0) 54 (90.0) 50 (83.3)
Missing 1 0 1 0 0
Maternal education 0.68
Low 55 (23.0) 19 (27.5) 11 (22.0) 13 (21.7) 12 (20.0)
Moderate 126 (52.7) 36 (52.2) 30 (60.0) 30 (50.0) 30 (50.0)
High 58 (24.3) 14 (20.3) 9 (18.0) 17 (28.3) 18 (30.0)
Missing 1 0 0 0 0
Residence < 0.001
Urban 171 (72.1) 38 (55.9) 26 (52.0) 55 (91.7) 52 (88.1)
Rural 66 (27.9) 30 (44.1) 24 (48.0) 5 (8.3) 7 (11.9)
Missing 3 1 1 0 0
Gestational age (weeks) 0.98
≥37 225 (93.8) 64 (92.8) 48 (94.1) 57 (95.0) 56 (93.3)
< 37 15 (6.3) 5 (7.3) 3 (5.9) 3 (5.0) 4 (6.7)
Missing 0 0 0 0 0
Drinking water < 0.001
Bottled 174 (72.8) 40 (58.0) 31 (62.0) 53 (88.3) 50 (83.3)
Public 49 (20.5) 23 (33.3) 15 (30.0) 6 (10.0) 5 (8.3)
Spring 16 (6.7) 6 (8.7) 4 (8.0) 1 (1.7) 5 (8.3)
Missing 1 0 1 0 0
Type of bathing 0.91
Shower only 221 (94.5) 63 (94.0) 48 (98.0) 55 (84.8) 55 (91.7)
Bath only 5 (2.1) 2 (3.0) 0 (0.0) 1 (1.7) 2 (3.3)
Both 8 (3.4) 2 (3.0) 1 (2.0) 2 (3.5) 3 (5.0)
Missing 6 2 2 2 0
Swimming pool use 0.24
Ever 229 (98.7) 67 (100.0) 47 (97.9) 57 (100.0) 58 (96.7)
Never 3 (1.3) 0 (0.0) 1 (2.1) 0 (0.0) 2 (3.3)
Missing 8 2 3 3 0
Hand dishwashing 0.21
No 82 (35.2) 25 (37.3) 13 (27.1) 26 (44.8) 18 (30.0)
Yes 151 (64.8) 42 (62.7) 35 (72.9) 32 (55.2) 42 (70.0)
Missing 7 2 3 2 0
All variables correspond to maternal characteristics during pregnancy.
aNumber of subjects with micronuclei analyses (either mother or newborn). bBrominated trihalomethanes in residen-
tial water quartiles: 0.06–0.15; > 0.15–0.74; > 0.74–4.44; > 4.44–7.09 μg/L. cp-Value based on Fisher exact test for table 
 frequencies (excluding the missing values). dExposed to secondhand smoke either at work or at home. 
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living in a rural area (10%). The percentage 
of women in the highest quartile of BTHM 
who consuming bottled water only (28%) was 
greater than those who consumed public (9%) 
or spring (4%) water.
Residential exposure to BTHMs during 
pregnancy. For the entire pregnancy, the 
mean concentration of BTHM in residential 
water was 2.1 ± 2.6 μg/L and the median 
was 0.8 μg/L. The minimum residential con-
centration was 0.06 μg/L and the maximum 
was 7.1 μg/L. Average BTHM concentrations 
over pregnancy were strongly correlated for 
the first and second trimester [Pearson cor-
relation coefficient (r) = 0.70] and the second 
and third trimester (r = 0.73), but the cor-
relation between the first and third trimester 
was weaker (r = 0.31). The mean maternal 
exposure through all routes was estimated to 
be 0.06 ± 0.10 μg/week. There was a strong 
positive correlation between mean residential 
water BTHM concentrations and estimated 
maternal BTHM exposure through all routes 
(r = 0.74, p < 0.001). Data for residential 
water concentrations and all route exposure 
estimates were missing and imputed for 
25 (12%) mothers and 28 (13%) newborns.
MN frequency distribution. The mean 
MN frequency per 1,000 BN was 2.85 ± 2.20 
(range, 0.00–15.88) in the 214 maternal blood 
samples and 1.80 ± 1.51 (range, 0.00–8.47) in 
the 223 cord blood samples (p < 0.001, paired 
t-test comparing mother and newborn counts 
based on the 162 paired samples). The mean 
frequency of MN per 1,000 MONO was 
0.71 ± 1.04 (range, 0.00–6.79) for the moth-
ers and 0.62 ± 0.72 (range, 0.00–4.19) for the 
newborns (p = 0.37, paired t-test for mother–
newborn comparison). The mean CBPI was 
1.64 ± 0.25 (range, 1.08–2.16) for maternal 
cultures and 1.57 ± 0.20 (range, 1.03–1.98) 
for the cord blood cultures (p = 0.99, for 
paired t-test for mother–newborn compari-
son). A trend of increasing mean MN frequen-
cies with increasing pregnancy mean BHTM 
exposures was observed for both BN (p = 0.07) 
and MONO (p = 0.02) in mothers only (see 
Supplemental Material, Table S1).
Regression model findings. Compared with 
taking showers only, taking baths only was 
associated with an increased frequency of MN 
in maternal BN [rate ratio (RR) = 2.08; 95% 
CI: 1.09, 3.98] and MN in maternal MONO 
(RR = 6.72; 95% CI: 3.21, 14.05) based on 
five mothers who only used a bath (Table 2). 
The frequency of MN in maternal MONO 
also increased with the number of baths per 
week (RR = 1.30; 95% CI: 1.08, 1.55 per 
bath), and with the product of duration and 
the frequency of bathing per week (RR = 1.65; 
95% CI: 1.23, 2.21 for 60 min of bathing 
per week). Conversely, the frequency of MN 
in maternal MONO decreased with frequent 
showering (RR = 0.88; 95% CI: 0.82, 0.95 
for each additional shower per week) and with 
the product of duration and the frequency 
of showering per week (RR = 0.72; 95% CI: 
0.52, 1.00 for 60 min of showering per week). 
Similar findings were observed for the analyses 
of the MN in maternal BN for bathing and 
showering duration and times per week except 
that these findings were not statistically signifi-
cant. Compared with public water as a drink-
ing source, maternal consumption of spring 
water only was associated with decreasing MN 
frequency in maternal MONO lymphocytes 
(RR = 0.26; 95% CI: 0.10, 0.70, based on 16 
women who used spring water), and nonsig-
nificantly related to decreased MN in maternal 
BN and MONO in newborns.
The results from modeling the fre-
quency of MN in BN in mothers and new-
borns using continuous exposure variables 
are presented in Table 3. Associations were 
closer to the null when adjusted for covari-
ates compared with unadjusted estimates (see 
Supplemental Material, Tables S2–S4). The 
frequency of MN in maternal BN increased 
with BTHM concentrations in residential 
water during the first and second trimesters 
(RR = 1.05; 95% CI: 1.00, 1.11 p = 0.06 
and RR = 1.03; 95% CI: 1.00, 1.06 p = 0.04 
per 1-μg/L increase in BTHM, respectively) 
and with the average concentration during 
pregnancy (RR = 1.03; 95% CI: 0.99, 1.07, 
p = 0.13). When residential BTHM concen-
trations were categorized into quartiles (data 
not shown), adjusted RRs for the frequency 
of MN in maternal BN in the highest quar-
tile relative to the first quartile were 1.28 
(95% CI: 0.97, 1.70) and 1.24 (95% CI: 
0.95, 1.61) for concentrations during the first 
Table 2. Associations between maternal water usage habits and micronuclei frequency per 1,000 BN and 
MONO lymphocytes from maternal blood and newborns cord blood samples [RR (95% CI)].
Variable
Maternal blood cellsa Newborns cord blood cellsb
BN MONO BN MONO
Type of bathing
Showers only 1.00 1.00 1.00 1.00
Baths only 2.08 (1.09, 3.98)* 6.72 (3.21, 14.1)# 1.07 (0.80, 1.42) 1.13 (0.62, 2.07)
Both 0.79 (0.54, 1.16) 0.20 (0.04, 1.05) 1.17 (0.70, 1.78) 1.13 (0.59, 2.14)
Showering
Times per week 0.98 (0.95, 1.00) 0.88 (0.82, 0.95)** 0.98 (0.96, 1.01) 1.03 (0.99, 1.07)
Durationc 0.96 (0.86, 1.08) 0.86 (0.66, 1.12) 0.86 (0.75, 1.00)* 0.93 (0.77, 1.13)
Times × durationd 0.95 (0.87, 1.05) 0.72 (0.52, 1.00)** 0.84 (0.73, 0.97)* 1.06 (0.91, 1.24)
Bathing
Times per week 1.09 (0.97, 1.23) 1.30 (1.08, 1.55)** 1.09 (0.99, 1.19) 1.06 (0.95, 1.18)
Durationc 1.06 (0.92, 1.23) 1.30 (0.97, 1.74) 1.07 (0.93, 1.22) 1.02 (0.82, 1.26)
Times × durationd 1.19 (0.96, 1.47) 1.65 (1.23, 2.21)** 1.15 (0.92, 1.44) 1.15 (0.90, 1.48)
Swimming pool usee 0.88 (0.32, 2.42) 1.19 (0.49, 2.88) 1.08 (0.32, 3.66) 1.74 (0.29, 10.41)
Drinking water source
Public water 1.00 1.00 1.00 1.00
Bottled 0.88 (0.68, 1.13) 0.75 (0.43, 1.33) 1.12 (0.82, 1.52) 0.78 (0.55, 1.09)
Spring 0.79 (0.54, 1.16) 0.26 (0.10, 0.70)** 1.09 (0.68, 1.74) 0.75 (0.37, 1.51)
Hand dishwashingf 1.11 (0.89, 1.37) 0.76 (0.44, 1.34) 0.89 (0.70, 1.15) 0.89 (0.66, 1.21)
RRs and 95% CIs of the micronuclei frequency from negative binomial models.
aModels for mothers controlled for maternal age at birth (years), maternal active smoking (nonsmokers/ex-smokers/
active smokers), workplace and home SHS (no/yes), living in an urban area (no/yes), maternal education (low/middle/
high), and maternal Greek ethnicity (yes/no). bModels for newborns controlled for the same variables as the maternal 
models except that maternal age was replaced by gestational age (weeks). cResults presented are for 10 min of shower-
ing or bathing. dResults presented are for 60 min of showering or bathing per week. eResults presented are for compari-
son of never (reference group) and ever used swimming pool during pregnancy. fResults presented are for comparison 
of dishwashing by machine (reference group) and hand. *p < 0.05. **p < 0.01. #p < 0.001. 
Table 3. Associations between brominated trihalomethanes and micronuclei frequency in BN cells from 
maternal and cord blood samples [RR (95% CI)].
Exposure Mothersa Newbornsb
Residential tap water (μg/L)
1st trimester 1.05 (1.00, 1.11) 1.02 (0.95, 1.08)
2nd trimester 1.03 (1.00, 1.06) 0.99 (0.96, 1.02)
3rd trimester 1.00 (0.98, 1.03) 0.98 (0.95, 1.01)
Full pregnancy 1.03 (0.99, 1.07) 0.98 (0.94, 1.03)
All routes of exposure (μg/week)
1st trimester 3.14 (1.16, 8.50) 0.90 (0.23, 1.48)
2nd trimester 1.68 (0.76, 3.73) 0.56 (0.26, 1.21)
3rd trimester 0.76 (0.40, 1.45) 0.59 (0.28, 1.24)
Full pregnancy 1.55 (0.59, 4.09) 0.51 (0.19, 1.36)
RRs and 95% CI of the micronuclei frequency in maternal mononucleated cells from negative binomial models (per 1 unit 
of exposure increment).
aAdjusted for maternal age at birth, maternal tobacco smoking, maternal exposure to workplace and home SHS, living in 
an urban area, maternal education, and Greek ethnicity. bModels for newborns controlled for the same variables as the 
maternal models except that maternal age was substituted by gestational age at birth (weeks).
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and second trimesters, respectively. However, 
residential BTHM concentrations during the 
third trimester were not associated with MN 
in maternal BN (p = 0.95).
A 1-μg/week increase in BTHM expo-
sures from all routes during the first trimester 
also was associated with higher frequency of 
MN in maternal BN (RR = 3.14; 95% CI: 
1.16, 8.50 p = 0.03) (Table 3). The association 
with BTHM exposures from all routes during 
the second trimester was also associated with 
elevated MN frequency in maternal BN, but 
this association was statistically nonsignificant 
(RR = 1.68; 95% CI: 0.76, 3.73 p = 0.2).
Plots of the model-predicted  exposure–
response relationships between residen-
tial BTHM water concentrations and the 
frequency of MN in maternal BN from 
unadjusted models are presented in the 
Supplemental Material, Figure S1. A restricted 
cubic spline with 3 knots is also included in the 
plots as a means of assessing the linearity of the 
exposure–response trends. These plots indicate 
that the linear models provide a reasonable fit 
to the estimates from the categorical and cubic 
spline models. Similar trends were evident 
when models with adjustment for the a priori 
covariates (results not shown).
There was no evidence of associations 
between any of the BTHM exposure mea-
sures and the frequency of MN in cord blood 
BN (see Supplemental Material, Table S2). 
For both mothers and newborns, there was 
no evidence of an association between any 
of the BTHM exposure estimates and the 
MN frequency in MONO (see Supplemental 
Material, Table S3 and Table S4).
Inclusion of additional covariates had 
little influence on model estimates (data not 
shown). Estimates were comparable to those 
shown when the analysis was restricted to the 
subset of study population with complete data 
(i.e., without the use of multiple imputation 
to impute missing data) (data not shown).
Mixed models that included a random 
effect for water systems had no influence 
on the exposure regression coefficients, but 
increased the precision and reduced the 
p-values for the estimated effect of BTHM 
exposures during the first trimester for resi-
dential exposures (from p = 0.03 to p = 0.01) 
and for all routes of exposure (from p = 0.01 
to p < 0.001). Only minor changes were 
observed in the results for the other BTHM 
regression parameters.
A statistically significant interaction was 
observed between maternal smoking (non-
smokers/ex-smokers/active smokers) and 
BHTM exposures experienced during the first 
trimester for both residential water concentra-
tions (p < 0.001) and all routes of exposure 
(p = 0.02) for MN frequency in maternal 
BN. Stratified analyses revealed that BHTM 
exposures during the first trimester were not 
associated with MN in maternal BN among 
the 145 nonsmokers for either residential 
water (RR = 0.99; 95% CI: 0.93, 1.04) or 
for all routes of BHTM exposure (RR = 1.23; 
95% CI: 0.34, 4.50) (see Supplemental 
Material, Table S5). A highly significant 
(p = 0.002) association was estimated for resi-
dential BHTM contaminants among the 48 
active smokers (RR = 1.11; 95% CI: 1.04, 
1.18). A borderline significant (p = 0.07) asso-
ciation was estimated for all routes of expo-
sure among the 48 active smokers (RR = 3.97; 
95% CI: 0.88, 17.99) and for residential 
water contaminants among the 44 ex-smokers 
(RR = 1.18; 95% CI: 0.99, 1.42).
Statistically significant (p < 0.01) inter-
actions were also observed in the models for 
MN in maternal BN between maternal educa-
tion and the all routes of exposure variables 
for second and third trimesters, and for the 
average over the pregnancy. The inter action 
for maternal education and all routes of 
exposure during the first trimester was nearly 
statistically significant (p = 0.10). Stratified 
analyses indicated that positive associations 
with all routes of BHTM exposure were only 
evident among the 47 women with low edu-
cation (1st trimester: RR = 18.09; 95% CI: 
1.31, 250.04; 2nd trimester: RR = 7.98; 95% 
CI: 1.17, 37.17; 3rd trimester: RR = 1.59; 
95% CI: 0.55, 4.63; and pregnancy aver-
age: RR = 10.88; 95% CI: 1.70, 69.48) (see 
Supplemental Material, Table S6).
Discussion
To our knowledge, the present study is the 
first to examine the relationship between 
exposure to BTHM and MN frequency in 
maternal and cord blood lymphocytes. We 
found evidence of a significant increase of MN 
frequency in maternal BN with BTHM expo-
sures during the first and second trimesters. 
An association between BTHM exposures 
during the third trimester and maternal MN 
frequency in BN was not evident. There was 
also no evidence of BTHM exposures being 
associated with either maternal MN frequency 
in MONO or MN frequency in newborns.
Our finding of an association between 
exposure to BTHMs and higher MN fre-
quency in maternal BN lymphocytes are con-
sistent with two other epidemiologic studies. 
Villanueva et al. (2006) reported an increase 
in the frequency of MN in exfoliated urine 
cells with higher BTHM exposures among 
adults. Kogevinas et al. (2010) also reported 
an association between BTHM in exhaled 
breath and an increased frequency of MN in 
BN lymphocytes in adults following swim-
ming in an indoor pool. However, a third 
study conducted in Australia did not find an 
association between THM in drinking water 
and MN frequency in urothelial cells from 
adults (Ranmuthugala et al., 2003).
There is some support for the biologic 
plausibility of our findings of an association 
from experimental studies. BTHM have been 
found to be genotoxic in experimental sys-
tems (Le Curieux et al. 1995). Brominated 
DBPs were reported to be more mutagenic 
and cytotoxic than chlorinated DBPs based 
on in vitro assays of Chinese hamster ovary 
cells (Plewa et al. 2010). Experimental stud-
ies based on animal models or in vitro assays 
have provided inconsistent findings regard-
ing the effects of brominated compounds on 
MN frequency. MN in cells exposed in vitro 
increased linearly with the concentration 
of bromide ions (Nobukawa and Sanukida 
2001). MN frequency in the mouse bone 
marrow was not found to increase following 
a single intraperitoneal injection of bromo-
dichloromethane and dibromochloromethane 
(Hayashi et al. 1988). Intraperitoneal injec-
tion of bromoform induced MN in one study 
(Melnick 1989), but not by gavage in another 
(Stocker et al. 1997). MN induction was 
observed in p53 (±) transgenic mice exposed 
by inhalation, but only at high concentra-
tions (15 ppm) relative to environmental 
 levels (Torti et al. 2002). The tissue, route, 
and short duration of exposure in these stud-
ies make them of questionable value for evalu-
ating the risk of MN formation in humans 
following chronic exposures to mixtures of 
BTHM by multiple routes.
Of course it is possible that our positive 
findings might be the result of unrecognized 
confounding. There are no obvious indus-
trial sources of pollution in the residential 
areas that were included in this study. Age has 
been strongly associated with higher MN fre-
quency in adults, particularly among women, 
which was also true in our models. Tobacco 
smoke and air pollution have also been associ-
ated with higher MN frequency (Pedersen 
et al. 2009; Rossnerova et al. 2011; Zalacain 
et al. 2006). Our findings are adjusted for 
both active smoking and SHS, and for liv-
ing in an urban or rural area. It is possible 
that residual confounding may exist by these 
factors, because we did not have the level of 
smoking, and residing in an urban area is a 
crude proxy for air pollution. In Heraklion, 
phthalates have been detected in water storage 
tanks that are used during periods of water 
shortages. However, insufficient informa-
tion is available to quantify the potential for 
 exposure to phthalates from these tanks.
We are not aware of a biologic mecha-
nism that would explain stronger associations 
with exposures during the first trimester than 
exposures during other trimesters. There was 
no a priori time period during which we 
expected a maximum effect, and we estimated 
effects by trimester primarily for the new-
borns. A possible explanation is that the expo-
sure estimates were based on the residence 
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around the third month of pregnancy; thus, 
the potential for exposure misclassification 
was the smallest during the first trimester. 
However, residential mobility among preg-
nant women was very low in this population 
(9%) (Patelarou et al. 2011).
The association of BTHM with MN 
in maternal BN was modified by smoking 
and maternal education. Significant posi-
tive associations were estimated only among 
women who smoked during their pregnancy, 
and among women with less education. The 
interaction with education may be related 
to factors not assessed in this study, such as 
exposure to ambient air pollution, a maternal 
diet high in genotoxic compounds, and/or 
low in antioxidants, but might also simply 
be a chance finding related to the multiple 
comparisons performed in this study. There 
is limited biologic support in the literature 
for an interaction with smoking. Smoking has 
been shown to increase expression of glutathi-
one S-transferase (GST) (Thum et al. 2006), 
which is a key metabolic pathway for the bio-
transformation and genotoxicity of BTHM 
(DeMarini et al. 1997; Pegram et al. 1997).
There was no evidence in our study 
that exposure to BTHM had any effect on 
the MN frequency in lymphocytes from 
cord blood. It has been shown that small 
THM molecules, such as chloroform, can 
pass from the maternal circulation to the 
fetal circulation through the placenta 
(Dowty et al. 1976). The lack of associa-
tions between exposures and MN in new-
borns might be explained by the fact that 
the maternal– placental–fetal circulation 
becomes established only around the 10th 
week of pregnancy, whereas the majority of 
lymphocytes collected at birth in cord blood 
are produced during the third trimester 
(Blackburn 2007). If the critical window of 
exposure was during the first trimester, then 
the cord blood lymphocytes collected at birth 
may not have been exposed. Another possible 
biologic explanation is that certain BTHM 
are metabolized by GST to reactive mutagens 
(DeMarini et al. 1997; Pegram et al. 1997), 
and it is likely that in utero metabolism of 
BTHM is immature, resulting in a lower 
exposure of the reactive toxic metabolites of 
THM to the fetus (Wild and Kleinjans 2003).
Exposure to BTHM was not associated 
with higher MN frequencies in MONO in 
either mothers or newborns. This might be 
explained by the fact that MN in MONO is 
less common than MN in BN, resulting in 
lower statistical power. Another explanation is 
that MN frequencies in MONO are thought 
to provide an estimate of genomic instability 
accumulated over many years in stem cells and 
circulating T lymphocytes, whereas MN in 
BN provide a measure of the lesions that have 
accumulated in the DNA or in key proteins 
since the lymphocytes last replicated in vivo 
(Kirsch-Volders and Fenech 2001; Kirsch-
Volders et al. 2011). Thus, the estimates of 
BTHM exposures over the course of the preg-
nancy may not be relevant for studying MN 
frequencies in MONO for the mothers, which 
may have been influenced by earlier exposures.
Taking baths was strongly associated with 
MN frequency in maternal BN and MONO 
lymphocytes based on a small number of 
women who did not use showers (n = 5). 
Bathing has been reported to result in a higher 
uptake of THM through both skin absorp-
tion and inhalation than showering (Gordon 
et al. 1998). Furthermore, in the present study 
population, the duration of bathing was on 
average longer than the time showering (32 vs. 
14 min), increasing the potential for exposure 
to BTHM. Compared with the 43 women 
who consumed public water, the 11 women 
who consumed only spring water had a 
reduced frequency of MN in MONO lym-
phocytes. Spring water is generally not chlo-
rinated, so women consuming spring water 
would have low exposures to THM in their 
drinking water.
This study had a number of strengths and 
some weaknesses as well. The strengths include 
the fact that MN frequency was available from 
a relatively large and well-characterized sample 
of maternal and cord blood, and that BTHM 
concentrations were estimated at both resi-
dential and personal levels. Potential variation 
related to the use of multiple scores of the 
lymphocytes and the MN was reduced as a 
semi-automatic imaged based scoring system 
was developed and applied in the current 
study (Decordier et al. 2009; Vande Loock 
et al. 2011).
There were multiple potential sources of 
exposure classification error in our study. The 
models developed were based on a limited 
number of water analyses. The models assume 
that all of the homes within the same water 
system have the same level of exposures, and 
thus ignores potential spatial variation within 
the water systems. The addresses were gener-
ally from early pregnancy, and it was assumed 
that the mothers did not move later in their 
pregnancies. Self-reported estimates of water 
habits are likely to be prone to error. These 
errors are all expected to be non-differential 
with respect to MN formation. Under these 
conditions these errors generally, but not 
always, bias the exposure response toward the 
null (Armstrong 1998).
The estimated BTHM concentrations 
in residential water supplies for our study 
population were lower than concentrations 
reported for other populations. For example, 
the average residential THM concentra-
tion for a Spanish population was 33 μg/L 
(Villanueva et al. 2006), compared with a 
mean BTHM concentration of only 2 μg/L in 
our study. The residential drinking-water con-
centrations in our population were also much 
lower than the current permissible regulatory 
limits, which are 100 μg/L in the European 
Union and 80 μg/L in the United States.
In conclusion, we observed significant 
increases in the frequency of MN in maternal 
BN in association with exposure to BTHM in 
residential water during the first and second 
trimesters of pregnancy. We also observed an 
association between increased MN frequency 
in women who took baths, and a decreased 
frequency of MN among women who con-
sumed primarily spring water, based on small 
numbers of observations. If these findings 
truly reflect a causal association, they may 
have important health and policy implica-
tions, particularly because the BTHM expo-
sures in this study were considerably lower 
than the current standards limits for BTHM 
in drinking water.
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Erratum
All EHP content is accessible to individuals with disabilities. A fully accessible (Section 508–compliant) 
HTML version of this article is available at http://dx.doi.org/10.1289/ehp.122-A68. 
Erratum: “Exposure to Brominated Trihalomethanes in Water During Pregnancy and Micronuclei Frequency in 
Maternal and Cord Blood Lymphocytes”
In the article “Exposure to Brominated Trihalomethanes in Water During Pregnancy and Micronuclei Frequency in Maternal and Cord 
Blood Lymphocytes” by Stayner et al. [Environ Health Perspect 122:100–106 (2014)], there was an error in Table 1. The number of 
women in exposure quartile 4 who had missing data for maternal smoking was given as zero instead of 3. The corrected table appears 
below and has also been corrected online.
EHP regrets the error.
Table 1. Study population characteristics [n (%)]a for all and by quartiles of the residential exposure to 
brominated trihalomethanes during the full pregnancy.b
Characteristic All (n = 240) Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-Valuec
Ethnicity 0.82
Greek 205 (86.3) 60 (88.2) 43 (84.3) 50 (83.3) 30 (88.1)
Other 33(13.9) 8 (11.8) 8 (15.7) 10 (16.7) 7 (11.9)
Missing 2 1 0 0 1
Maternal age (years) 0.24
≤ 35 210 (87.8) 65 (94.2) 44 (88.0) 50 (83.3) 51 (85.0)
> 35 29 (12.1) 4 (5.8) 6 (12.0) 10 (16.7) 9 (15.0)
Missing 1 0 1 0 0
Maternal smoking 0.06
Nonsmokers 145 (61.2) 45 (65.2) 33 (68.9) 28 (46.7) 39 (65.0)
Ex-smokers 44 (18.6) 16 (23.2) 5 (10.4) 14 (23.3) 9 (15.0)
Active smokers 48 (20.2) 8 (11.6) 10 (20.8) 18 (30.0) 12 (20.0)
Missing 3 0 3 0 3 
SHSd 0.42
Not exposed 26 (10.9) 5 (7.3) 5 (10.0) 6 (10.0) 10 (16.7)
Exposed 213 (89.1) 64 (92.8) 45 (90.0) 54 (90.0) 50 (83.3)
Missing 1 0 1 0 0
Maternal education 0.68
Low 55 (23.0) 19 (27.5) 11 (22.0) 13 (21.7) 12 (20.0)
Moderate 126 (52.7) 36 (52.2) 30 (60.0) 30 (50.0) 30 (50.0)
High 58 (24.3) 14 (20.3) 9 (18.0) 17 (28.3) 18 (30.0)
Missing 1 0 0 0 0
Residence < 0.001
Urban 171 (72.1) 38 (55.9) 26 (52.0) 55 (91.7) 52 (88.1)
Rural 66 (27.9) 30 (44.1) 24 (48.0) 5 (8.3) 7 (11.9)
Missing 3 1 1 0 0
Gestational age (weeks) 0.98
≥37 225 (93.8) 64 (92.8) 48 (94.1) 57 (95.0) 56 (93.3)
< 37 15 (6.3) 5 (7.3) 3 (5.9) 3 (5.0) 4 (6.7)
Missing 0 0 0 0 0
Drinking water < 0.001
Bottled 174 (72.8) 40 (58.0) 31 (62.0) 53 (88.3) 50 (83.3)
Public 49 (20.5) 23 (33.3) 15 (30.0) 6 (10.0) 5 (8.3)
Spring 16 (6.7) 6 (8.7) 4 (8.0) 1 (1.7) 5 (8.3)
Missing 1 0 1 0 0
Type of bathing 0.91
Shower only 221 (94.5) 63 (94.0) 48 (98.0) 55 (84.8) 55 (91.7)
Bath only 5 (2.1) 2 (3.0) 0 (0.0) 1 (1.7) 2 (3.3)
Both 8 (3.4) 2 (3.0) 1 (2.0) 2 (3.5) 3 (5.0)
Missing 6 2 2 2 0
Swimming pool use 0.24
Ever 229 (98.7) 67 (100.0) 47 (97.9) 57 (100.0) 58 (96.7)
Never 3 (1.3) 0 (0.0) 1 (2.1) 0 (0.0) 2 (3.3)
Missing 8 2 3 3 0
Hand dishwashing 0.21
No 82 (35.2) 25 (37.3) 13 (27.1) 26 (44.8) 18 (30.0)
Yes 151 (64.8) 42 (62.7) 35 (72.9) 32 (55.2) 42 (70.0)
Missing 7 2 3 2 0
All variables correspond to maternal characteristics during pregnancy.
aNumber of subjects with micronuclei analyses (either mother or newborn). bBrominated trihalomethanes in residen-
tial water quartiles: 0.06–0.15; > 0.15–0.74; > 0.74–4.44; > 4.44–7.09 μg/L. cp-Value based on Fisher exact test for table 
frequencies (excluding the missing values).  dExposed to secondhand smoke either at work or at home. 
